Sort
38,696 grants matching “als”
Developmental methylomics of childhood trauma and its health consequences
$622,056Edwin Van Den Oord · Virginia Commonwealth University · R01 · FY2015 · MH
Therapeutic strategies for microsatellite expansion diseases using RNA-targeting CRISPR/Cas
$622,054Eugene Wei-Ming Yeo · University Of California, San Diego · R01 · FY2018 · NS
Towards Therapeutics for Neurodegenerative Diseases
$621,851Stanley B Prusiner · University Of California, San Francisco · R37 · FY2014 · AG
Impact of harm reduction care in HIV clinical settings on stigma and health outcomes for PLWH who use drugs
$621,799Mary Elizabeth Hawk · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DA
T cell immunity in a rare juvenile form of motor neuron disease
$621,769Ivan Marazzi · University Of California-Irvine · R01 · FY2024 · NS
Analysis of vascular cell senescence to identify interventions in atherosclerosis
$621,754Allison Herman · National Institute On Aging · ZIA · FY2025 · AG
Preclinical Testing of Targeted Therapies for Neurofibromas
$621,744David W. Clapp · Indiana University Indianapolis · U01 · FY2010 · NS
Preclinical Testing of Targeted Therapies for Neurofibromas
$621,744David W. Clapp · Indiana University Indianapolis · U01 · FY2010 · NS
BRAIN project (Histed): Readout and Control of Spatiotemporal Neuronal Codes of Behavior
$621,600Mark Histed · National Institute Of Mental Health · ZIA · FY2019 · MH
Association of ALS to gene-environment mediated changes in HDL proteins
$621,473Teepu Siddique · Northwestern University At Chicago · R01 · FY2015 · ES
Defining Dysbiosis and Mechanisms of Periodontitis Progression and Stability
$621,437Flavia Rocha Teles · University Of Pennsylvania · R01 · FY2025 · DE
Charting the trajectory of executive control in autism in order to optimize delivery of intervention
$621,373Susan Faja · Boston Children'S Hospital · R01 · FY2019 · MH
Sensitive, Integrating Multi-Waveguide Biosensor
$621,342Cha-Mei Tang · Creatv Microtech, Inc. · R44 · FY2007 · CA
Exercise and QUality diet After Leukemia
$621,296Emily Smith Tonorezos · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
BCR signaling during B cell development and maintenance
$621,140Michael Craig Carroll · Immune Disease Institute, Inc. · R37 · FY2011 · AI
HIV prevention with adolescents: Neurocognitive deficits and treatment response
$621,132Angela D Bryan · University Of New Mexico · R01 · FY2010 · AA
Commercialization of TrueContour® Custom Diabetic Foot Orthoses
$621,123Peter Robert Cavanagh · Diapedia, Llc · SB1 · FY2017 · DK
Pathogenesis of Clade C HIV Infection
$621,120Bruce D Walker · Massachusetts General Hospital · R37 · FY2020 · AI
Stress Granules and the Biology of TDP-43
$621,092Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2012 · ES
Molecular Basis of Pathogenic Cascades in ALS/FTD Initiated from C9orf72 Hexanucleotide Repeat Expansion
$621,007Jiou Wang · Johns Hopkins University · R01 · FY2023 · NS
Multifunctional Porous Soft Materials for User-Friendly Skin-Interfaced Bimodal Cardiac Patches with Long-Term Biocompatibility and Antimicrobial Property
$620,987Zheng Yan · University Of Missouri-Columbia · R01 · FY2024 · EB
Noninvasive Assessment of Neuromuscular Disease using Electrical Impedance
$620,921Jose Luis Bohorquez · Myolex, Inc. · R44 · FY2012 · NS
The altered lipid and protein metabolism of pediatric patients with HIV infection
$620,915Farook Jahoor · Baylor College Of Medicine · R01 · FY2008 · HD
IDENTIFICATION OF MELANOMA PREDISPOSITION LOCI
$620,911University Of Utah · R01 · FY2005 · CA
Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD
$620,824Justin Kawika Ichida · University Of Southern California · R01 · FY2022 · NS